CHEM 30B
Dr. R. Rinehart
I. Fat
digestion, absorption, and transport
A. Digestion:
requires emulsification by bile salts
and hydrolysis by pancreatic lipase
B. Products: monoglycerides,
diglycerides, fatty acids, glycerol
C. Absorbed as mixed
micelles; triglycerides resynthesized in mucosal cells and packaged
as chylomicra; released into lymphatic
circulation; eventually enter blood;
blood
levels of TG peak ~4 hr after meal, remain elevated > 10 hrs
D. Plasma lipoproteins: classified by behavior when centrifuged [also by electrophoresis]
CLASS àProperty |
chylomicra |
VLDL |
LDL |
HDL |
|
diameter, Å |
750-12000 |
300-800 |
180-250 |
50-120 |
|
flotation
constant |
Sf
> 400 |
Sf 20-400 |
Sf 0-20 |
--- |
|
density,
g/mL |
<0.95 |
0.95-1.006 |
1.019-1.063 |
1.063-1.210 |
|
% triglyceride |
80-90 |
55-65 |
10 |
5 |
|
% phospholipid |
3-6 |
15-20 |
22 |
30 |
|
% cholesterol |
2-7 |
10-15 |
45 |
20 |
|
% protein |
1-2 |
5-10 |
25 |
45-50 |
|
apoprotein
types |
A-I,
AII, |
B-100 |
|
A-I,
A-II |
|
where
made |
intestine |
liver,
intestine, blood |
liver |
liver |
|
function |
deliver
dietary fat to muscle, heart, adipose tissues |
deliver
triglycerides & cholesterol |
deliver
cholesterol to other tissues |
return
cholesterol to liver |
|
Defects in cholesterol and lipoprotein
metabolism by Michael W. King at Indiana State U Medical School |
|
Heart and Stroke Encyclopedia by the American Heart
Association® |
E. Fat
mobilization: epinephrine and
other hormones stimulate “hormone-sensitive
lipase” in
adipose tissue; the resulting
glycerol and “free”
(unesterified) fatty acids enter the
blood,
where the fatty acids are carried
by serum albumin to muscle, heart,
liver, kidney, etc.
Glycerol taken up by cells is converted
to DHAP, which can then be catabolized by
glycolysis or used to yield glucose
via gluconeogenesis.
II. Fatty
acid oxidation [fats yield 9 kcal/g]
A. Activation:
further metabolism requires attachment to
CoA -- this process
requires the equivalent of 2 ATP
per fatty acid. This is a cytoplasmic
reaction, but further
degradation of the fatty acid
occurs in the mitochondrial matrix.
Transport of the fatty
acyl group across the mitochondrial inner membrane involves a carrier called carnitine,
a derivative of lysine, and two
membrane-bound molecules of carnitine acyltransferase.
B. Beta-oxidation
is the major catabolic pathway for fatty acids. It is a pseudo-cyclic or “spiral”
pathway in which a sequence of
four reactions is repeated until the entire molecule has
been split into acetyl-CoA. The pathway occurs in the mitochondrial matrix
1. Dehydrogenation of
RCH2CH2CH2
CO~SCoA with FAD to give FADH2 and
RCH2CH=CHCO~SCoA (a,b-unsaturated fatty acyl
CoA). This reaction is
analogous
to the succinate à
fumarate reaction of the Krebs cycle.
2. Hydration of the a,b
double bond to give a b-hydroxy
fatty acyl CoA
RCH2CH=CHCO~SCoA + H2O à
RCH2CHOHCH2CO~SCoA. This reaction
is
analogous to the fumarate à
malate reaction of the Krebs cycle.
3. Dehydrogenation of
the b
2o alcohol
with to give a b-ketoacyl CoA
RCH2CHOHCH2CO~SCoA
+ NAD+
à
RCH2COCH2CO~SCoA + NADH
+ H+
Analogous
to malate à
oxaloacetate.
4. Cleavage of the first
two carbons with HSCoA, yielding acetyl-CoA
and a shorter
fatty acyl CoA ready to go
through the cycle again.
RCH2COCH2CO~SCoA
+ HSCoA
à
RCH2CO~SCoA + CH3CO~SCoA
The
reactions of b-oxidation.
Each cycle shortens the chain by 2C
Initial activation:
RCO2H + HSCoA + ATP à
RCOSCoA + AMP + PPi
pyrophosphatase hydrolyzes
PPi to 2 Pi, so net energy loss for
this reaction is 2 ~Ⓟ
In the last cycle, butyryl-CoA à
2 AcCoA. Hence, C2n à
n AcCoA in (n-1) cycles
Each AcCoA gives 12 ATP from Krebs cycle and oxidative phosphorylation
Each cycle yields 1 NADH and 1 FADH2 or 5 ATP/cycle
overall
process including Krebs cycle and oxidative phosphorylation:
C2nH4nO2
+ (3n-1) O2
à
2n CO2 + 2n H2O
, with net formation of (17n-7) ATP
5. For a typical fatty acid
containing 2n
carbon atoms:
n
molecules of AcCoA are produced; 12n
ATP after they go through the Krebs cycle;
(n-1)
cycles are required; each cycle
produces one FADH2 and one
NADH
FADH2
yields 2 ATP and NADH
yields 3 ATP
after electron transport
The net energy yield for our C2n
fatty acid is thus:
12n
[AcCoA/Krebs+ETS] +
5(n-1)
[ETS per cycle] -
2 [activation rxn]
or 17n – 7 ATP
[other books using lower ATP from ETS may state this as 14n-6]
|
Errors in mitochondrial fatty acid
oxidation by Michael W. King at Indiana State U School of Medicine |
C. Ketogenesis:
under conditions of starvation, diabetes mellitus, or carbohydrate deprivation,
b-oxidation
and amino acid oxidation increase. In
the liver, excess AcCoA is
converted
to acetoacetate, a b-ketoacid which
can be reduced with NADH to b-hydroxybutyrate;
Both of these molecules are water-soluble
fuels for aerobic tissues (brain,
heart, muscle)
However, they are also acids, and overproduction,
as in diabetes, leads to “ketoacidosis”.
Excess acetoacetate gives rise to acetone
via spontaneous decarboxylation; it is volatile
enough to be expelled by the lungs and can be detected in the exhalation of
uncontrolled
diabetics. The three compounds (acetoacetate,
b-hydroxybutyrate, acetone)
are
collectively known as “ketone
bodies” .
[KB]
> 20 mg% =
ketonemia; > 70 mg%
produces ketonuria
ketosis
= ketonemia + ketonuria +
acetone breath
ketoacidosis = ketosis with a
plasma pH below 7.35; causes loss of minerals,
dehydration, coma, and death.
D. Ethanol metabolism [I should have covered this when we did aerobic
metabolism].
An aerobic process, occurs in the liver; net energy yield: 16
ATP/mole EtOH, 7 kcal/g

Ethanol catabolism increases the cellular NADH/NAD+ ratio, thus inhibiting
glycolysis and
b-oxidation.
As little as 6 weeks of heavy drinking causes fatty infiltration of the
liver, which is
reversible in the early stages, but which can progress to irreversible cirrhosis
of the liver.
Prolonged heavy drinking also induces a "microsomal ethanol-oxidizing
system" [MEOS],
which, although it does lead to an increased capacity to metabolize ethanol, causes
other
alterations in liver metabolism that are also deleterious.
III. Fatty
acid synthesis: occurs in adipose
tissue and liver when carbohydrates
are plentiful.
A.
Occurs in cytosol; uses a multienzyme
fatty acid synthase complex with acyl
carrier protein
B.
2C from AcCoA leave
mitochondrial matrix as citrate and
AcCoA is regenerated in cytosol
C. Energy from ATP
and reducing power from NADPH (a
modified form of NADH produced in
the “pentose pathway”) and the
vitamin biotin and CO2 are also required
D.
The actual reactions look pretty much like a reversal of
b-oxidation
E.
Newly-synthesized fatty acids are converted to triglycerides.
| PowerPoint slides on lipid, amino acid,
drug, and alcohol metabolism by James Hardy at U Akron http://ull.chemistry.uakron.edu/genobc/Chapter_24/ |
|
Lipid metabolism by James Blair at Oklahoma State http://web.archive.org/web/20030110014145/http://opbs.okstate.edu/~Blair/Bioch2344/Chapter13/Chapter13.htm http://opbs.okstate.edu/~Blair/Bioch2344/Chapter13/Chapter13.htm |
| Animations of fat digestion, cytoplasmic
activation of fatty acids, and transport across the inner mitochondrial membrane by carnitine from Harcourt Brace, publishers of Interactive Biochemistry by Garrett & Grisham http://www.brookscole.com/chemistry_d/templates/student_resources/shared_resources/animations/carnitine/carnitine1.html |
| Lipid metabolism by Michael W. King
at Indiana State U Medical School http://web.indstate.edu/thcme/mwking/lipid-synthesis.html |
| Metabolic Pathways of Biochemistry
by Karl J. Miller at George Washington U http://www.gwu.edu/~mpb/ > Lipid Metabolism |
IV. Amino
acid metabolism
A.
Protein digestion and absorption
stomach: pepsin; intestine:
trypsin, chymotrypsin, carboxypeptidases, aminopeptidases,
elastase, di- and tri-peptidases. Absorption is
a complex process requiring a Na+
gradient and
an additional 3
ATP/AA; as
a result, the body will net 2.8
kcal/g instead of the theoretical
4-4.5 kcal/g
B. Amino
acid pool: from diet, recovery of AA from degraded proteins, and synthesis
(nonessential)
~75% of pool used for protein
synthesis; protein
turnover: continuous synthesis
&
hydrolysis of body proteins; different proteins have different turnover
rates.
C. Specialized
products from amino acids:
TYR:
dopamine, norepinephrine, epinephrine, thyroxine, melanin
TRP:
serotonin, melatonin
HIS:
histamine
SER: ethanolamine, cephalins
CYS: taurine, b-mercaptoethylamine in HSCoA
LYS: carnitine
GLY, TRP, MET, ARG, etc:
feed the “one-carbon pool” used
in all sorts of processes including
synthesis of thymine,
choline, carnitine, creatine, ……
GLU: GABA, a
neurotransmitter
GLN:
NH3 for urine buffering, N donor for purine
& pyrimidine synthesis
ASP:
converted to NMDA, a neurotransmitter
|
See more on specialized products from
amino acids by Michael W. King at Indiana State U Medical School |
D. Catabolism:
20 AA with >1 pathway each; we’ll just hit the high points;
first, remove the
a-amino
group by transamination and deamination
and convert the nitrogen to urea;
then, transform the carbon skeleton to useful goodies like Krebs
intermediates, glucose
and ketone bodies. Most steps occur
in mitochondrial matrix of the liver
E. Transamination:
requires pyridoxal phosphate (a vit. B6
derivative) and a-KG or OAA (from
the Krebs cycle), yielding an a-keto
carbon skeleton and GLU or ASP.
E. (Oxidative) deamination: GLU + NAD+
à
aKG + NADH +
NH4+
F. The urea
cycle converts CO2, NH4+
and the a-NH2
group of ASP to urea, a neutral water-
soluble molecule excreted in the urine. Net
energy requirement 4 ATP / urea made
Works in conjunction with the Krebs cycle
G. Carbon
skeleton fates:
1. If catabolism yields AcCoA and/or AcAcCoA, the amino acid is ketogenic
ILE, LEU*,
TRP, LYS, PHE, TYR are ketogenic
[* = exclusively ketogenic]
2.
If catabolism yields Krebs
intermediates and/ or pyruvate or
other C3 compounds,
the
amino acid is glucogenic [† = exclusively glucogenic]
ALA†,
GLY†, CYS†, SER†, THR, TRP, ASP†, ASN†,
GLU†, GLN†, HIS†,
PRO†,
ARG†, ILE, MET†, VAL†, PHE, TYR, LYS
are glucogenic
H. Biosynthesis of
nonessential amino acids: usually glycolysis intermediates or Krebs
intermediates
provide the C-skeleton and transamination delivers the N;
PHE à
TYR; defect in this
process causes phenylketonuria (PKU), a
very serious inborn error of metabolism.
I. There are plenty of
other, but much rarer, hereditary disorders of amino acid metabolism that
your book doesn’t mention!
| See inborn disorders of amino acid
metabolism by
Michael W. King at Indiana State U Medical School http://web.indstate.edu/thcme/mwking/inborn.html#amino |
| Nitrogen metabolism by Michael W.
King at Indiana State U Medical School http://web.indstate.edu/thcme/mwking/nitrogen-metabolism.html |
| Amino acid metabolism [all 20 of 'em]
by Michael W. King at Indiana State U Medical School http://web.indstate.edu/thcme/mwking/amino-acid-metabolism.html |
| Amino acid metabolism by James Blair
at Oklahoma State U http://web.archive.org/web/20030507234455/http://opbs.okstate.edu/~Blair/Bioch2344/Chapter14/Chapter14.htm http://opbs.okstate.edu/~Blair/Bioch2344/Chapter14/Chapter14.htm |
| and don't forget the ultimate: Biochemical
Pathways from Boehringer Mannheim via ExPASy http://us.expasy.org/cgi-bin/search-biochem-index |
© Ronald W. Rinehart, 2002-2007 Structures drawn with MDL IsisDraw®